Ironwood Pharmaceuticals to Present at Upcoming Investor Conferences
CAMBRIDGE, Mass.--(BUSINESS WIRE)--
Pharmaceuticals, Inc. (NASDAQ: IRWD) will present at the Goldman
Sachs 33rd Annual Global Healthcare Conference on Tuesday,
June 5, 2012 at 8:40 a.m. Pacific Time (11:40 a.m. Eastern Time) at
Terranea Resort in Rancho Palos Verdes, CA.
In addition, Ironwood management will also present at the Jefferies 2012
Global Healthcare Conference on Tuesday, June 5, 2012 at 4:00 p.m.
Eastern Time at the Grand Hyatt New York.
A live webcast of Ironwood's presentations will be accessible through
the Investors section of the company's website at www.ironwoodpharma.com.
To access the webcasts, please log on to the Ironwood website
approximately 15 minutes prior to the start time to ensure adequate time
for any software downloads that may be required. A replay of the
webcasts will be available on Ironwood's website for 14 days following
About Ironwood Pharmaceuticals
Ironwood Pharmaceuticals (NASDAQ: IRWD) is an entrepreneurial
pharmaceutical company dedicated to the art and science of great
drugmaking. Linaclotide, Ironwood's guanylate cyclase-C agonist (GCCA),
is an investigational drug for the treatment of irritable bowel syndrome
with constipation (IBS-C) and chronic constipation. The efficacy portion
of linaclotide's development program has been completed and supports the
submitted NDA submission for both indications, as well as the MAA
submission in Europe for the IBS-C indication. Ironwood also has a
growing pipeline of additional drug candidates in earlier stages of
development. Ironwood is located in Cambridge, Mass. To learn more,
Ironwood Pharmaceuticals, Inc.
Meredith Kaya, 617-374-5082
Source: Ironwood Pharmaceuticals, Inc.
News Provided by Acquire Media
Close window | Back to top